Shaw Christi bought BEAM
June 3, 2026 · Form 4 insider transaction
Shaw Christi bought 19,676 shares of Beam Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,676
Price
$0.00
Total value
N/A
InsiderShaw Christi
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after19,676
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.